Diabetes decreases patency of tunneled catheters in hemodialysis patients after first effective thrombolysis with urokinase

Renal Failure
Dominika WójtowiczJerzy Chudek

Abstract

Fibrinolysis is one of the methods extending the use of vascular access in patients with tunneled venous catheters thrombosis. The aim of this study was to assess one-year maintenance of tunneled catheters patency after first effective thrombolysis with urokinase and identify its predictors. Retrospective analysis included 85 patients (age 69 ± 13 years) with permanent venous catheter thrombosis treated with urokinase at one center in the period 2010-2016. Urokinase was used (depending on weight) at a dose of 10,000 or 20,000 IU in an 8 h infusion to each catheter line. Assessment of one-year efficacy of fibrinolysis included the time between fibrinolysis and following thrombosis of the same catheter in patients that have previously obtained at least partial blood flow. The analysis included medication, comorbidities, catheter patency time and INR value during first thrombosis episode. There were 62.4% patients with type-2 diabetes and 11.8% with neoplasm. The thrombolysis procedure was effective in 73 patients (85.9%). An analysis of the one-year efficacy of thrombolysis procedure included 73 patients. Among them, 23 experienced next episode of catheter-related thrombosis within a year postprocedure. Diabetes increased the ris...Continue Reading

References

Jan 5, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Mark A Little, J Joseph Walshe
Feb 20, 2002·Seminars in Dialysis·G A Beathard
Dec 31, 2002·The Annals of Pharmacotherapy·James M ZachariasLavern M Vercaigne
Sep 15, 2005·ASAIO Journal : a Peer-reviewed Journal of the American Society for Artificial Internal Organs·Michael ZellwegerFrançois Madore
Jan 25, 2007·Seminars in Dialysis·Anil K AgarwalNabil J Haddad
Aug 19, 2007·Clinical Journal of the American Society of Nephrology : CJASN·Louise M MoistCharmaine E Lok
Feb 7, 2008·Seminars in Dialysis·Lisa Willms, Lavern M Vercaigne
Jan 28, 2011·The New England Journal of Medicine·Brenda R HemmelgarnUNKNOWN Prevention of Dialysis Catheter Lumen Occlusion with rt-PA versus Heparin Study Group
Feb 23, 2011·Arquivos brasileiros de endocrinologia e metabologia·Paulo Cezar FortesRoberto Pecoits-Filho
Oct 31, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Amanda Y WangMeg J Jardine
Jul 15, 2015·Jornal brasileiro de nefrologia : ʹorgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia·Marcela Lara MendesDaniela Ponce
Feb 8, 2016·Hemodialysis International·Viviane PolloDaniela Ponce
Mar 10, 2016·The Journal of Vascular Access·Maurizio GallieniMaurizio Cariati
Mar 10, 2017·Journal of Evidence-based Medicine·Georgios Vlachopanos, Farid Girgis Ghalli
Jun 9, 2017·Clinical Science·Erik WesteinAnna C Calkin

❮ Previous
Next ❯

Citations

May 18, 2021·Diabetes & Metabolic Syndrome·Fakhriya Alalawi, Alaaeldin Bashier
Jun 15, 2021·Vascular and Endovascular Surgery·Emre SelçukFath Avni Bayraktar

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Software Mentioned

STATISTICA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.